Indication:
Drug Name- Invokana
Active Ingredient - Canagliflozin
Canagliflozin
Indication-
Used with diet and excercise to improve glycemic control in adults
with type 2 diabetes
Approved by FDA on 29-3--2013 (Ref- FDA approved List- 2013)
Canagliflozin Tablet 100mg/300mg
Indication-
Indicated as an adjunct to diet and excercise to improve glycemic control in
adults with Type -2 Diabetes Mellitus
Approved by FDA on 17-11--2014 (Ref- FDA approved List- 2014)
New drugs approved For Marketing by Drug Controller General of India(DCGI )
during the period January 1988 to November 2014
(Ref- IDMA Annual Publication 2015)
Name of Drug Indication Date of Approval
Canaglifloxin tablet 100mg/300mg 17-11-2014
Indicated as an adjunct to diet and excercise to improve glycemic
control in adults with type 2 diabetic mellitus
Canagliflozin Tablet 100mg/300mg
Indication-
Indicated as an adjunct to diet and excercise to improve glycemic control in
adults with Type -2 Diabetes Mellitus
Approved by FDA on 17-11--2014 (Ref- FDA approved List- 2014)
Dosages/ Overdosage Etc:
Indication-
Indicated as an adjunct to diet and excercise to improve glycemic control in
adults with Type -2 Diabetes Mellitus
Manufacturer Details